A Trial of a Modified Cystoscopy Method to Reduce Pain Perception

A Randomized Control Trial of a Modified Cystoscopy Method to Reduce Pain Perception

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT03257293

Enrollment

Registered

2017-08-22

Start date

2018-04-01

Completion date

2020-08-01

Last updated

2021-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer, Bladder Disease, Hematuria

Brief summary

The goal of this project is to improve patient experience of cystoscopy using a non-pharmacologic modification of procedure. Cystoscopy is a common outpatient procedure for urology patients and is usually performed without sedation. However, there is limited research into reduction of patient discomfort throughout this procedure. The proposed modification technique was selected based on a well-documented psychological phenomenon in which only particular moments over the course of an aversive event determine the resultant perception of the experience. It is hypothesized that implementation of the technique will decrease the recalled pain intensity of the cystoscopy.

Interventions

BEHAVIORALModified Cystoscopy

The objective of this study is to examine whether a non-pharmacologic modification in procedure of cystoscopies improves patient perception of pain and discomfort.

BEHAVIORALRoutine Cystoscopy

Routine cystoscopy as done as part of routine clinical practice

Study design

Allocation

RANDOMIZED

Intervention model

PARALLEL

Primary purpose

SUPPORTIVE_CARE

Masking

SINGLE (Subject)

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patients over the age of 18 undergoing cystoscopy for the first time for diagnostic investigation will be approached to participate in this study.

Exclusion criteria

* Cystoscopies involving other interventions concurrently (e.g. biopsy, urethral dilation, removal of ureteral stent, etc.) will be excluded. * Patients currently taking medication for chronic pain (e.g. opioids, Tricyclic antidepressants (TCAs)) will be excluded from the study. * Patients less than 18 years of age will be excluded. * Patients who have received a cystoscopy previously will be excluded.

Design outcomes

Primary

Measure	Time frame	Description
Pain Experience rated on the visual analogue scale	1 hour	The primary outcome of the study will be pain experience, as rated on the visual analogue scale provided.

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026